indication
as of 2026-07-01Stable Schizophrenia
Competitive landscape projected to Second Generation Antipsychotics (SGA)’s launch window
Competitive set
0
0 approved · 0 pipeline
Projection timeline
actual past → guided future · protection walls overlaid
1 events
2020
2022
2024
2026
2028
2030
today
Second Generation Antipsychotics (SGA) launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff
Competitive set
resolved drugs with trials in this indicationNothing in the set matches — the product only shows what’s in the data.
Market size
prevalence as a range, not a number